Your browser doesn't support javascript.
loading
Loss of toll-like receptor 5 potentiates spontaneous hepatocarcinogenesis in farnesoid X receptor-deficient mice.
Golonka, Rachel M; Yeoh, Beng San; Saha, Piu; Gohara, Amira; Tummala, Ramakumar; Stepkowski, Stanislaw; Tiwari, Amit K; Joe, Bina; Gonzalez, Frank J; Gewirtz, Andrew T; Vijay-Kumar, Matam.
Afiliação
  • Golonka RM; Department of Physiology and Pharmacology, UT Microbiome Consortium, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.
  • Yeoh BS; Department of Physiology and Pharmacology, UT Microbiome Consortium, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.
  • Saha P; Department of Physiology and Pharmacology, UT Microbiome Consortium, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.
  • Gohara A; Department of Pathology, University of Toledo Medical Center, Toledo, Ohio, USA.
  • Tummala R; Department of Physiology and Pharmacology, UT Microbiome Consortium, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.
  • Stepkowski S; Department of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.
  • Tiwari AK; Department of Pharmacology and Experimental Therapeutics, The University of Toledo, Toledo, Ohio, USA.
  • Joe B; Department of Physiology and Pharmacology, UT Microbiome Consortium, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.
  • Gonzalez FJ; Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Gewirtz AT; Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia, USA.
  • Vijay-Kumar M; Department of Physiology and Pharmacology, UT Microbiome Consortium, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.
Hepatol Commun ; 7(6)2023 06 01.
Article em En | MEDLINE | ID: mdl-37219858
ABSTRACT

BACKGROUND:

HCC is the most common primary liver cancer and a leading cause of cancer-related mortality. Gut microbiota is a large collection of microbes, predominately bacteria, that harbor the gastrointestinal tract. Changes in gut microbiota that deviate from the native composition, that is, "dysbiosis," is proposed as a probable diagnostic biomarker and a risk factor for HCC. However, whether gut microbiota dysbiosis is a cause or a consequence of HCC is unknown.

METHODS:

To better understand the role of gut microbiota in HCC, mice deficient of toll-like receptor 5 (TLR5, a receptor for bacterial flagellin) as a model of spontaneous gut microbiota dysbiosis were crossed with farnesoid X receptor knockout mice (FxrKO), a genetic model for spontaneous HCC. Male FxrKO/Tlr5KO double knockout (DKO), FxrKO, Tlr5KO, and wild-type (WT) mice were aged to the 16-month HCC time point.

RESULTS:

Compared with FxrKO mice, DKO mice had more severe hepatooncogenesis at the gross, histological, and transcript levels and this was associated with pronounced cholestatic liver injury. The bile acid dysmetabolism in FxrKO mice became more aberrant in the absence of TLR5 due in part to suppression of bile acid secretion and enhanced cholestasis. Out of the 14 enriched taxon signatures seen in the DKO gut microbiota, 50% were dominated by the Proteobacteria phylum with expansion of the gut pathobiont γ-Proteobacteria that is implicated in HCC.

CONCLUSIONS:

Collectively, introducing gut microbiota dysbiosis by TLR5 deletion exacerbated hepatocarcinogenesis in the FxrKO mouse model.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colestase / Carcinoma Hepatocelular / Receptor 5 Toll-Like / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Revista: Hepatol Commun Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colestase / Carcinoma Hepatocelular / Receptor 5 Toll-Like / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Revista: Hepatol Commun Ano de publicação: 2023 Tipo de documento: Article